%0 Journal Article
%T Predictive biomarkers and effectiveness of MUC1-targeted dendritic-cell-based vaccine in patients with refractory non-small cell lung cancer
%A Jun Hanaoka
%A Keiichi Kontani
%A Koji Teramoto
%A Noriaki Tezuka
%A Satoru Sawai
%A Shozo Fujino
%A Yataro Daigo
%A Yoshitomo Ozaki
%J Archive of "Therapeutic Advances in Medical Oncology".
%D 2017
%R 10.1177/1758834016678375
%X The dendritic cell (DC)-based vaccine targeting the highly immunogenic tumor antigen, MUC1, has been promising for a cancer immunotherapy; however, predictive biomarkers for beneficial clinical responses of the vaccine remain to be determined
%K cancer immunotherapy
%K dendritic-cell-based vaccine
%K MUC1 tumor antigen
%K non-small cell lung cancer
%K predictive biomarker
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349424/